VICINI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.872
EU - Europa 2.062
AS - Asia 1.729
SA - Sud America 243
AF - Africa 45
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 6.962
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.792
IT - Italia 795
SG - Singapore 516
CN - Cina 494
GB - Regno Unito 433
BR - Brasile 183
VN - Vietnam 168
HK - Hong Kong 165
SE - Svezia 155
IE - Irlanda 148
DE - Germania 128
BD - Bangladesh 91
FI - Finlandia 82
RU - Federazione Russa 65
KR - Corea 62
FR - Francia 54
IN - India 51
ID - Indonesia 42
CA - Canada 40
NL - Olanda 38
UA - Ucraina 38
MX - Messico 26
AR - Argentina 23
TR - Turchia 21
JP - Giappone 20
BG - Bulgaria 16
BE - Belgio 13
AE - Emirati Arabi Uniti 12
AT - Austria 12
ES - Italia 12
LT - Lituania 12
PL - Polonia 12
ZA - Sudafrica 12
CO - Colombia 11
MY - Malesia 11
MK - Macedonia 10
PH - Filippine 10
CL - Cile 9
IQ - Iraq 9
PK - Pakistan 9
SA - Arabia Saudita 9
CZ - Repubblica Ceca 8
GR - Grecia 7
AU - Australia 6
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
VE - Venezuela 6
MA - Marocco 5
TH - Thailandia 5
TN - Tunisia 5
UZ - Uzbekistan 5
AL - Albania 4
CR - Costa Rica 4
ET - Etiopia 4
JO - Giordania 4
NG - Nigeria 4
CY - Cipro 3
DO - Repubblica Dominicana 3
EG - Egitto 3
IL - Israele 3
RS - Serbia 3
BH - Bahrain 2
HN - Honduras 2
IR - Iran 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RO - Romania 2
A1 - Anonimo 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AQ - Antartide 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
Totale 6.958
Salva come PNG Salva come JPEG
Città #
Singapore 356
Ashburn 339
Santa Clara 326
Southend 303
Fairfield 184
Chandler 164
Hong Kong 162
Hefei 158
San Jose 153
Dublin 140
Ann Arbor 103
Woodbridge 103
Beijing 89
Houston 79
Nyköping 77
Seattle 76
Los Angeles 74
Council Bluffs 71
Wilmington 69
Dearborn 62
Jacksonville 62
London 62
Milan 59
Bologna 58
Ho Chi Minh City 58
New York 58
Cambridge 57
Modena 56
Seoul 55
Helsinki 52
The Dalles 47
Hanoi 43
Rome 37
Jakarta 36
Chicago 31
Munich 31
Shanghai 28
Reggio Emilia 27
San Diego 25
Boardman 22
Lauterbourg 19
Bremen 18
Orem 18
Dallas 16
Eugene 16
Frankfurt am Main 16
Moscow 16
Princeton 16
Sofia 16
São Paulo 16
Turin 16
Turku 16
Bari 15
Buffalo 14
Tokyo 14
Toronto 14
Florence 13
Brussels 12
Parma 12
Redwood City 11
Amsterdam 10
Hillsboro 10
Mexico City 10
Nuremberg 10
Palermo 10
Warsaw 10
Izmir 9
Kent 9
Lappeenranta 9
Redondo Beach 9
Denver 8
Falls Church 8
Haiphong 8
Salt Lake City 8
Atlanta 7
Belo Horizonte 7
Chennai 7
Poplar 7
Boston 6
Buenos Aires 6
Chengdu 6
Ferrara 6
Fulham 6
Kuala Lumpur 6
Monterrey 6
Montreal 6
Paris 6
Phoenix 6
Stockholm 6
Tampa 6
Brasília 5
Brescia 5
Catania 5
Da Nang 5
Fremont 5
Hangzhou 5
Kunming 5
Las Vegas 5
Newark 5
Perugia 5
Totale 4.574
Salva come PNG Salva come JPEG
Nome #
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 491
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 485
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 411
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 404
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 376
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 350
"It's All COVID's Fault!": Symptoms of Distress among Workers in an Italian General Hospital during the Pandemic 339
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 304
Predictive role of capillaroscopic skin ulcer risk index in systematic sclerosis: a multicentre validation study 273
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 272
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 271
Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial 266
Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol 260
Preoperative carboplatin-paclitaxel-bevacizumab in triple negative breast cancer: Final results of the phase II CA.Pa.Be study 257
Biomarker expression and survival after primary chemotherapy for breast cancer. 245
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial 236
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 217
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial 210
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 197
Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 196
Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial 189
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 174
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 166
Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials 151
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 143
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 134
Totale 7.017
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022389 17 31 26 12 10 26 16 31 51 23 103 43
2022/2023651 53 61 40 46 57 62 16 50 195 12 27 32
2023/2024577 31 26 33 57 54 54 63 73 36 46 51 53
2024/20251.426 37 25 45 110 254 230 101 78 155 51 129 211
2025/20262.591 216 103 191 284 389 128 337 110 219 293 229 92
Totale 7.017